By Research Area
Hot products 
-
Human Anti-SARS-CoV-2 S1 Monoclonal Antibody (CBFYR-0120) (CBMAB-R0120-FY)
-
Mouse Anti-CCS Recombinant Antibody (CBFYC-1093) (CBMAB-C1150-FY)
-
Mouse Anti-ACLY Recombinant Antibody (V2-179314) (CBMAB-A0610-YC)
-
Mouse Anti-CD83 Recombinant Antibody (HB15) (CBMAB-C1765-CQ)
-
Mouse Anti-C4B Recombinant Antibody (CBYY-C2996) (CBMAB-C4439-YY)
-
Mouse Anti-ANXA7 Recombinant Antibody (A-1) (CBMAB-A2941-YC)
-
Mouse Anti-DLL4 Recombinant Antibody (D1090) (CBMAB-D1090-YC)
-
Mouse Anti-BIRC3 Recombinant Antibody (315304) (CBMAB-1214-CN)
-
Mouse Anti-ADIPOR2 Recombinant Antibody (V2-179983) (CBMAB-A1369-YC)
-
Mouse Anti-BBS2 Recombinant Antibody (CBYY-0253) (CBMAB-0254-YY)
-
Mouse Anti-DLG1 Monolconal Antibody (4F3) (CBMAB-0225-CN)
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-0790) (CBMAB-0793-YY)
-
Mouse Anti-CFL1 (Phospho-Ser3) Recombinant Antibody (CBFYC-1770) (CBMAB-C1832-FY)
-
Mouse Anti-DES Monoclonal Antibody (440) (CBMAB-AP1857LY)
-
Mouse Anti-BLNK Recombinant Antibody (CBYY-0623) (CBMAB-0626-YY)
-
Rat Anti-(1-5)-α-L-Arabinan Recombinant Antibody (V2-501861) (CBMAB-XB0003-YC)
-
Mouse Anti-BACE1 Recombinant Antibody (61-3E7) (CBMAB-1183-CN)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Mouse Anti-ATP1B3 Recombinant Antibody (1E9) (CBMAB-A4021-YC)
-
Mouse Anti-CARTPT Recombinant Antibody (113612) (CBMAB-C2450-LY)
Lung Cancer Research
Lung cancer, formally known as primary bronchogenic carcinoma, originates from the epithelial cells of the bronchial mucosa or glands, which is one of the most prevalent malignancies worldwide. It is primarily classified into non-small cell lung cancer (NSCLC) and SCLC based on histopathological characteristics. While lung cancer is non-contagious, it exhibits significant familial clustering and genetic susceptibility. Common causes of lung cancer involve smoking, occupational exposure, and air pollution. According to the latest global cancer report released by the International Agency for Research on Cancer (IACR) in 2024, lung cancer ranks first in both new cases (12.4%) and deaths (18.7%), making it the leading cancer worldwide, particularly among men.
Discover our advanced antibody products, which will significantly enhance your work in lung cancer diagnosis and treatment research. These antibodies are carefully designed to possess high specificity and sensitivity, enabling accurate biomarker identification and assessment.
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Reference
- Lahiri, Aritraa, et al. "Lung cancer immunotherapy: progress, pitfalls, and promises." Molecular cancer 22.1 (2023): 40. Distributed under Open Access license CC BY 4.0. The image was modified by extracting and using only Part B of the original image.
Loading...
Compare
